The Latest Cardiac and Vascular News
JERUSALEM, May 15, 2018 /PRNewswire/ — BrainQ, developing Artificial Intelligence (AI) powered technologies to treat neurodisorders in innovative ways, today announced the completion of a financing round, making the total investment in the Company to date stand at $8.8M. The financing included Qure Ventures, OurCrowd.com, Norma Investments, IT-Farm, and other strategic angel investors […]
NEW YORK, May 14, 2018 /PRNewswire/ — Parker Waichman LLP is investigating potential personal injury and defective medical device claims related to adverse events associated with the use of Neurovascular Stents for Stent-Assisted Coiling (SAC) for the treatment of unruptured brain aneurysms. The Food and Drug Administration (FDA) has received […]
OXFORD, England, May 11, 2018 / PRNewswire / – e-CTA pro provides fast automated collateral evaluations that use IA and big data and are based on CTA analysis Brainomix, a medical imaging software company that uses artificial intelligence (AI) for rapid diagnosis and treatment of stroke victims, has received CE Mark approval for its new e-CTA […]
FREMONT, Calif. and OXFORD, England, May 11, 2018 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company engaged in the design and development of highly differentiated and proprietary interventional neuroradiology devices and delivery systems for the treatment of acute, life-threatening neurological conditions, specifically, intracranial aneurysm, today announced the promotion of Stephen Griffin, PhD, […]
WEST VALLEY CITY, Utah–(BUSINESS WIRE)–Scientia Vascular, an early stage medical device company with patented and proprietary vascular access technology, recently received FDA clearance for a new product called the Aristotle 14 guidewire, which is used during ischemic and hemorrhagic strokes and other challenging interventional procedures. The Aristotle guidewire improves access […]
KALAMAZOO, Michigan, USA, May 7, 2018 /PRNewswire/ — Following the expanded indication in the United States by the Food and Drug Administration (FDA) in February, Stryker’s Trevo Retriever has received CE marking as a front-line treatment for patients experiencing acute ischemic stroke up to 24 hours from symptom onset, increasing the treatment window by 18 […]
Menlo Park, Calif. – May 1, 2018 – iSchemaView, the leader in cerebrovascular imaging analysis, today announced it has received final clearance from the U.S. Food and Drug Administration (FDA) for RAPID CTA, the company’s 3D imaging solution for Computed Tomography Angiography. RAPID CTA is the newest addition to iSchemaView’s industry […]
Today, the U.S. Food and Drug Administration permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients. A stroke is a serious medical condition that requires emergency care […]
KNOXVILLE, Tenn., April 24, 2018 /PRNewswire/ — Arkis BioSciences®, a leading innovator of next generation neurosurgical catheters and minimally invasive instrumentation, announced today that it is receiving promising clinical feedback for its new CerebroFlo™ External Ventricular Drainage (EVD) brain catheter. The company introduced the new catheter, incorporating the Endexo® molecule, into clinical use for […]
FLAGSTAFF, Ariz., April 3, 2018 /PRNewswire/ — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already […]
